Equities

TransGenic Group Inc

2342:TYO

TransGenic Group Inc

Actions
  • Price (JPY)203.00
  • Today's Change-5.00 / -2.40%
  • Shares traded45.70k
  • 1 Year change-21.01%
  • Beta1.1526
Data delayed at least 20 minutes, as of Nov 15 2024 06:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

TransGenic Group Inc, formerly Trans Genic Inc is a Japan-based company mainly engaged in the drug discovery support business and the investment and consulting business. The Company operates through two business segments. The Drug Discovery Support Business segment provides seamless services that can handle all stages of drug discovery, from the initial stages of drug discovery, such as basic research and drug discovery research, to non-clinical and clinical trials. Its main services include contract production of genetically modified mice, contract production of antibodies and glycosylation analysis and synthesis. The Investment and Consulting Business segment promotes new businesses through mergers and acquisitions (M&A) and provides advice and support services related to business succession and business revitalization in a wide range of fields.

  • Revenue in JPY (TTM)9.59bn
  • Net income in JPY-143.81m
  • Incorporated1998
  • Employees236.00
  • Location
    TransGenic Group IncibbFUKUOKA Bldg.2-3-36, Tenjin, Chuo-kuFUKUOKA-SHI 810-0001JapanJPN
  • Phone+81 922888470
  • Fax+81 922888473
  • Websitehttps://transgenic-group.co.jp/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
RAVIPA Ltd1.56bn81.86m1.01bn16.0012.349.0711.860.649341.3441.34785.4256.253.284.7418.8462,205,320.0017.28--29.55--79.32--5.26--2.1529.730.7382--28.74--327.54------
Yumemitsuketai Co Ltd506.72m153.08m1.07bn11.006.740.42046.952.1115.1315.1350.09242.620.15140.337733.1846,065,090.004.572.405.603.2044.7149.5530.1815.430.1249--0.22110.00105.801.22524.0010.74-33.59--
Creema Ltd2.52bn100.01m1.60bn80.0015.991.5411.490.63414.8214.82373.08153.650.7493--4.2631,472,080.002.980.33287.600.963677.9388.033.970.4764--9.410.28270.000.355816.88119.38---51.04--
P-Ban.Com Corp1.54bn71.75m1.77bn35.0023.191.2719.921.1515.3115.31328.53278.960.990860.016.6243,952,880.004.627.615.579.5234.2933.564.665.734.7046.44--29.930.0385-0.88090.4015-16.9628.979.86
ANAP Inc2.71bn-1.19bn1.83bn140.00------0.677-231.54-231.54528.21-404.972.183.7718.01---95.65-35.98---130.3447.8654.53-43.84-17.780.1141-53.025.36---35.75-15.43-1.96---17.85--
Micreed Co Ltd6.35bn236.00m3.37bn26.0014.352.6211.310.53135.6235.62957.61194.893.2320.598.70244,038,500.0012.064.6019.177.0034.2933.963.741.652.03--0.0016.5227.167.8965.6714.99-22.26--
Kuradashi Co Ltd2.86bn12.62m3.37bn49.00346.983.2389.221.180.89920.8992258.5396.542.0510.8250.2858,412,180.000.9026--1.15--46.49--0.4411--3.5247.090.1114---1.65--107.54------
TransGenic Group Inc9.59bn-143.81m3.54bn236.00--0.6117--0.3687-8.59-8.59571.67340.020.91073.066.7940,630,810.00-1.313.34-1.904.4916.5421.35-1.432.581.25-16.650.318318.2114.478.57101.00-54.18-3.68--
Tea Life Co Ltd13.00bn319.00m5.14bn161.0016.130.818410.700.395774.8574.853,051.511,474.851.489.8712.7380,751,550.003.636.454.277.8034.2340.432.454.253.22--0.139437.47-3.396.96-46.745.67-3.9818.13
Crooz Inc10.87bn-348.35m7.33bn594.00--0.5737--0.6748-34.01-34.011,039.36986.610.3726--4.1918,295,960.00-1.291.79-1.672.3742.9231.24-3.462.042.29--0.59330.001.92-13.97295.58---46.88--
Golf Digest Online Inc.55.50bn-1.57bn7.51bn1.46k----2.560.1353-86.22-86.223,049.0333.401.155.6215.3537,990,860.00-2.411.59-4.953.4632.6037.56-2.091.040.327--0.980739.4714.8114.63-169.62--26.43-15.89
Felissimo Corp28.81bn-836.00m8.44bn425.00--0.3185--0.2929-117.38-117.384,044.512,637.660.97482.9611.7267,776,470.00-2.831.95-3.722.7552.9753.58-2.901.981.83--0.0014.69-7.940.4971-227.87---7.4224.57
Data as of Nov 15 2024. Currency figures normalised to TransGenic Group Inc's reporting currency: Japanese Yen JPY

Institutional shareholders

0.03%Per cent of shares held by top holders
HolderShares% Held
DFA Australia Ltd.as of 31 May 20234.19k0.03%
Yuki Management & Research Co. Ltd.as of 31 Jan 20220.000.00%
Dimensional Fund Advisors LPas of 30 Jun 20240.000.00%
Data from 31 Jan 2022 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.